D
PharmaCyte Biotech, Inc. PMCB
$1.04 $0.032.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Total Cash And Short-Term Investments -13.50% -7.27% -19.60% -36.14% -34.96%
Total Receivables 24.68% -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 6.43% 7.91% -57.95% 105.33% -7.54%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -71.89% -- -- -- --
Total Current Assets -14.61% 31.90% -20.48% -35.11% -34.82%

Total Current Assets -14.61% 31.90% -20.48% -35.11% -34.82%
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles 0.00% 0.00% 0.00% 0.00% 0.00%
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -45.04% 31.17% -9.17% 10.69% -15.98%
Total Assets -18.23% 25.87% -20.45% -21.51% 17.18%

Total Accounts Payable 16.53% -17.67% 39.10% -37.08% 42.27%
Total Accrued Expenses -33.66% -26.54% 0.31% 3.38% -6.95%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -87.46% -- -- -40.33% -0.98%
Total Other Current Liabilities -87.46% -- -- -40.33% -0.98%
Total Current Liabilities -63.60% 144.00% -74.99% -36.09% 0.70%

Total Current Liabilities -63.60% 144.00% -74.99% -36.09% 0.70%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 26.17% -84.77% -65.30% -29.02% -25.35%
Total Liabilities -53.65% -8.41% -69.28% -32.10% -15.87%

Common Stock & APIC 0.03% 0.04% 0.04% -0.75% -1.41%
Retained Earnings -9.84% 12.15% -3.25% -1.59% 20.26%
Treasury Stock & Other 0.00% -0.39% -0.52% -3.31% -1.78%
Total Common Equity -15.99% 28.92% -7.37% -8.92% 72.56%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- -55.06%
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- -55.06%

Total Common Equity -15.99% 28.92% -7.37% -8.92% 72.56%
Total Preferred Equity -- -- -- -- -55.06%
Total Minority Interest -- -- -- -- --
Total Equity -15.99% 28.92% -7.37% -18.08% 34.23%